GT Biopharma (GTBP) Return on Capital Employed [ROCE] (2010 - 2026)
GT Biopharma (GTBP) posted Return on Capital Employed [ROCE] of -287.98% for Q2 2026, down 86.95 percentage points from the prior quarter.
Powered by 
Analysis
GT Biopharma (GTBP) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends
For FY2025, GT Biopharma's Return on Capital Employed [ROCE] came in at -322.65%, up 116.82 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of +341.80 percentage points (FY2021 to FY2025).
- In prior years, GT Biopharma's Return on Capital Employed [ROCE] was -439.47% in FY2024 (-285.01 pp), -154.46% in FY2023 (-45.53 pp), -108.93% in FY2022 (+555.52 pp) and -664.45% in FY2021.
- Quarterly Return on Capital Employed [ROCE] has run from a low of -410.89% in Q3 2024 to a high of -82.94% in Q3 2021 over five years.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2025, with a gain of 170.29 percentage points; the weakest was Q3 2024, with a drop of 276.64 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -201.02% (Q1 2026), -318.96% (Q4 2025) and -240.60% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 11.32% |
| 10 | GT Biopharma | 6.65 Mn | -16.58 Mn | - | -287.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -287.98% |
| Mar 31, 2026 | -201.02% |
| Dec 31, 2025 | -318.96% |
| Sep 30, 2025 | -240.60% |
| Sep 30, 2024 | -410.89% |
| Jun 30, 2024 | -227.89% |
| Mar 31, 2024 | -175.45% |
| Dec 31, 2023 | -159.80% |
| Sep 30, 2023 | -134.26% |
| Jun 30, 2023 | -140.74% |
| Mar 31, 2023 | -135.89% |
| Dec 31, 2022 | -152.21% |
| Sep 30, 2022 | -191.28% |
| Jun 30, 2022 | -189.53% |
| Mar 31, 2022 | -167.26% |
| Dec 31, 2021 | -242.43% |
| Sep 30, 2021 | -82.94% |
| Jun 30, 2021 | -79.10% |
| Mar 31, 2021 | -162.51% |
| Jun 30, 2019 | -2,745.02% |
API Access
GT Biopharma Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "GTBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=GTBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();